Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MiroTract Wound Matrix

K-Number: K231614 · 2023-12-13

Decision Date2023-12-13
Product CodeKGN
DecisionSubstantially Equivalent

Device Summary

MiroTract Wound Matrix is a medical device manufactured by Reprise Biomedical, Inc.. It received FDA 510(k) clearance on 2023-12-13 under approval number K231614. The device is classified under product code KGN. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MiroTract Wound Matrix?

MiroTract Wound Matrix is a medical device that received FDA 510(k) clearance on 2023-12-13. It is manufactured by Reprise Biomedical, Inc.. The 510(k) number is K231614.

When was MiroTract Wound Matrix approved by the FDA?

MiroTract Wound Matrix received FDA 510(k) clearance on 2023-12-13, under approval number K231614.

What company makes MiroTract Wound Matrix?

MiroTract Wound Matrix is manufactured by Reprise Biomedical, Inc..

What is the FDA product code for MiroTract Wound Matrix?

The FDA product code for MiroTract Wound Matrix is KGN.

Related Clinical Trials

Other Devices by Reprise Biomedical, Inc.

Related Devices (Code: KGN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.